Signaling Pathway
| Catalog No | Chemical Name | CAS Number | Purity | Chemical Structure |
|---|---|---|---|---|
| 24043 | AZD-5462 | 2787501-83-9 | ≧98.0% |  |
| AZD5462 is a small molecule agonist of the RXFP1 relaxin receptor. | ||||
| 24048 | Sebetralstat free base | 1933514-13-6 | 98% Min. |  |
| Sebetralstat (KVD-900), an oral plasma kallikrein inhibitor. | ||||
| 24015 | ASX-173 | 2748800-08-8 | ≧98.0% |  |
| ASX-173 is a compound that inhibit the activity of asparagine synthetase (ASNS). | ||||
| 24057 | NDI-091143 | 2375840-87-0 | ≧97.0% |  |
| NDI-091143 is a novel potent inhibitor of human ATP-citrate lyase, indirectly disrupt | ||||
| 24069 | Tuvusertib | 1613200-51-3 | ≧98.0% |  |
| Tuvusertib, also known as M-1774 and ATR inhibitor 1, is a ATR inhibitor. M1774 selec | ||||
| 24108 | JHU-083 | 1998725-11-3 | ≧98.0% |  |
| JHU-083 selectively blocks glutaminase activity in brain CD11b+ cells and prevents de | ||||
| 24109 | CBR-5884 | 681159-27-3 | ≧98.0% |  |
| CBR 5884 is a phosphoglycerate dehydrogenase (PHGDH) inhibitor which was able to inhi | ||||
| 24110 | VVD-130037 ( BAY-3605349 ) | 3034880-93-5 | ≧98.0% | _3034880-93-5.png) |
| VVD-130037 (BAY-3605349) is an oral, small-molecule activator of KEAP1 (INrf2). | ||||
| 24111 | PLX-4545 | 2892065-45-9 | ≧98.0% |  |
| PLX-4545 is an orally bioavailable molecular glue degrader of IKZF2 designed to desta | ||||
| 24112 | HC-5404-FU | 3034479-99-4 | ≧98.0% |  |
| HC-5404-FU is a novel, highly selective and potent PERK inhibitor. | ||||
| 24123 | Zastaprazan ( JP-1366 ) | 2133852-18-1 | ≧98.0% |  |
| Zastaprazan, also known as JP-1366, is a proton pump inhibitor. JP-1366 mediates stro | ||||
| 25001 | HC-5404 | 2247396-91-2 | ≧98.0% |  |
| HC-5404 is a novel, highly selective and potent PERK inhibitor. | ||||